Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT01352533
Other study ID # STU38040
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date July 2016
Est. completion date July 2017

Study information

Verified date December 2021
Source Northwestern University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to assess whether wound closure with skin adhesive or running stitches combined with skin adhesive will be superior to standard wound sutures. This is a split-wound study that will compare two methods of skin closure within one standard closure technique, thereby providing an internal control of running stitches within each wound. The investigators plan to measure outcomes by assessing for scar appearance, the incidence of wound opening, scar elasticity and subject satisfaction.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date July 2017
Est. primary completion date July 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age 18 and over - Linear closures on the head and neck, at least 3cm in length - The subjects are in good health - The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator. Exclusion Criteria: - Under 18 years of age - Pregnancy or Lactation - Subjects who are unable to understand the protocol or to give informed consent - Subjects with mental illness - Defects on the scalp

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Running polypropylene closure
Half of every wound will be closed with Standard of Care running polypropylene sutures
Tissue Adhesive (Derma-Bond)
Approximately half of wounds will be randomized to be closed with tissue adhesive.
Subcuticular polyglactin-910 combined with tissue adhesive
Approximately half of the experimental wounds will be randomized to be closed with a combination of subcuticular polyglactin-910 and tissue adhesive.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Outcome

Type Measure Description Time frame Safety issue
Primary Wound Healing The primary outcome measure of this study will be wound healing. This outcome will be assessed by the blinded observers, subject ratings and Cutometer measurements of scar elasticity. Two double-blinded dermatologists will be asked to rate the scars according to the objective scar scales at the 10 day/ 3 week and 3 month follow-up exams. 10 day/3 weeks and 3 months
Secondary Dehiscence The rate of dehiscence observed will be noted and recorded by the treating physicians. 10 days/3 weeks and 3 months
Secondary Subject Satisfaction The subjects will fill out the VAS to evaluate their overall assessment of their scar, any associated pruritus and pain. The subjects will also fill out a Subject Satisfaction Survey to evaluate subject preference for closure. 10 days/3 weeks and 3 months
Secondary Adverse Events The treating physicians will note occurrence and extent of any adverse events associated with either type of epidermal closure. 10 days/3 weeks and 3 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02991755 - Use of 5-0 Prolene Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure N/A
Completed NCT02383186 - Dermal Suturing Only Versus Layered Cutaneous Closure N/A
Completed NCT02289859 - Undermining During Cutaneous Wound Closure N/A
Completed NCT02547077 - Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure N/A
Completed NCT02550574 - Use of 2-octylcyanoacrylate With Full-thickness Skin Grafts N/A
Completed NCT02062866 - Evaluation of Purse-String Closure Vs Second Intention N/A